Page last updated: 2024-08-26

2-(4-bromo-2,5-dimethoxyphenyl)ethylamine and plx4032

2-(4-bromo-2,5-dimethoxyphenyl)ethylamine has been researched along with plx4032 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czemmel, S; Garbe, C; Groll, N; Ikenberg, K; Krueger, MA; Macek, B; Makino, E; Meier, F; Niessner, H; Pötz, O; Rothbauer, U; Schittek, B; Sinnberg, T; Velic, A1

Other Studies

1 other study(ies) available for 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine and plx4032

ArticleYear
A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib.
    EBioMedicine, 2016, Volume: 8

    Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Humans; Indoles; Melanoma; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Resin Cements; STAT3 Transcription Factor; Sulfonamides; Vemurafenib; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2016